The rising cost of healthcare is a national crisis that threatens to sink both individuals and the federal government into long-term debt. New York City based Truveris is trying to bring efficiency and transparency to the fastest growing piece of these costs, prescription drugs.
Received $10M Series B Funding
Participation New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures, First Round Capital
Truveris TruBid Epipheo
Received $3.8M Series A Funding
Participation GSA Venture Partners, New Atlantic Ventures, First Round Capital